Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spyre Therapeutics (SYRE) Prepaid Assets: 2015-2024

Historic Prepaid Assets for Spyre Therapeutics (SYRE) over the last 10 years, with Dec 2024 value amounting to $5.4 million.

  • Spyre Therapeutics' Prepaid Assets rose 168.62% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 168.62%. This contributed to the annual value of $5.4 million for FY2024, which is 139.27% up from last year.
  • Spyre Therapeutics' Prepaid Assets amounted to $5.4 million in FY2024, which was up 139.27% from $2.3 million recorded in FY2023.
  • Over the past 5 years, Spyre Therapeutics' Prepaid Assets peaked at $6.2 million during FY2022, and registered a low of $2.3 million during FY2023.
  • For the 3-year period, Spyre Therapeutics' Prepaid Assets averaged around $4.6 million, with its median value being $5.4 million (2024).
  • Per our database at Business Quant, Spyre Therapeutics' Prepaid Assets slumped by 63.53% in 2023 and then skyrocketed by 139.27% in 2024.
  • Spyre Therapeutics' Prepaid Assets (Yearly) stood at $3.5 million in 2020, then skyrocketed by 40.73% to $4.9 million in 2021, then climbed by 24.74% to $6.2 million in 2022, then tumbled by 63.53% to $2.3 million in 2023, then spiked by 139.27% to $5.4 million in 2024.